Inventor
OKADA HIDEHO
US19 patents
⚠️ This page may combine multiple inventors who share the name “OKADA HIDEHO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
6 patentsUS10441644B2Oct 15, 2019
H3.3 CTL peptides and uses thereof
UNIV CALIFORNIA4 citations82
US10849965B2Dec 1, 2020
H3.3 CTL peptides and uses thereof
UNIV CALIFORNIA2 citations71
US11925679B2Mar 12, 2024
H3.3 CTL peptides and uses thereof
UNIV CALIFORNIA0 citations60
US11185577B2Nov 30, 2021
H3.3 CTL peptides and uses thereof
UNIV CALIFORNIA0 citations60
US12090170B2Sep 17, 2024
Methods of treating glioblastomas
UNIV CALIFORNIA1 citations57
US12144826B2Nov 19, 2024
Methods of treating EGFRvIII expressing glioblastomas
UNIV CALIFORNIA0 citations46
NOVARTIS AG
3 patentsUS10308717B2Jun 4, 2019
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
NOVARTIS AG4 citations83
US11865167B2Jan 9, 2024
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
NOVARTIS AG2 citations72
US12559562B2Feb 24, 2026
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
NOVARTIS AG0 citations62
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
3 patentsUS10434155B2Oct 8, 2019
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION3 citations72
US11723963B2Aug 15, 2023
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations62
US10874730B2Dec 29, 2020
Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION1 citations62